Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Acuity Reports Fiscal 2026 Second-Quarter Results

Acuity Reports Fiscal 2026 Second-Quarter Results

Acuity Inc. delivered a robust second-quarter fiscal 2026 performance marked by 5% net sales growth to $1.1 billion, 21% increase in operating profit to $133 million, and a 26% rise in diluted EPS to $3.09. The company's two business segments had mixed results: Acuity Brands Lighting sales slightly declined by 2.8%, while Acuity Intelligent Spaces …

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Limited announced that founder, chairman, and CEO Yusheng Han purchased 31,487 American Depositary Shares (ADSs) for $546,603.90 on the open market, adding to prior purchases this year. These transactions signal strong insider confidence in the company's precision oncology business, which focuses on next generation sequencing (…

Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets

Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets

Scorpio Tankers Inc. has entered into a strategic collaboration with AMPERA, Inc. to jointly develop and commercialize advanced micronuclear power solutions aimed at powering maritime vessels, offshore, and port infrastructure with zero carbon emissions. The collaboration focuses on deploying ultra-safe micro nuclear reactors, including floating nu…

Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company

Freight Technologies announced significant progress in transforming into a software-first, AI-native logistics technology company, focusing on scaling its AI-powered platforms like Fleet Rocket, Zayren, and Fr8Radar. The company is exploring strategic alternatives for its traditional brokerage operations to concentrate resources on its AI software …

PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems Sector

PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems Sector

PMGC Holdings Inc. announced the formation of NorthStrive Defense Tech LLC, a wholly owned subsidiary targeting the high-growth defense technology sector, specifically drone and autonomous systems. This strategic move leverages PMGC's existing aerospace and defense subsidiaries to accelerate commercialization of advanced defense technologies throug…

Minerva Announces Leadership Transition

Minerva Announces Leadership Transition

Minerva Neurosciences, a clinical-stage biotech focused on CNS disorders, announced that Jim O'Connor will become Chief Business Officer, replacing departing President Geoff Race who will remain as consultant. The leadership change occurs as Minerva prepares to advance its key drug candidate, roluperidone, through a planned Phase 3 trial targeting …

Grocery Outlet Holding Corp. Adds Two New Independent Directors

Grocery Outlet Holding Corp. Adds Two New Independent Directors

Grocery Outlet Holding Corp., a U.S.-based extreme value retailer, announced the appointment of Frances Allen and Felicia Thornton to its Board of Directors to enhance expertise aligned with strategic priorities. Both bring extensive experience in grocery and retail sectors, brand strategy, marketing, finance, and operations. These strategic additi…

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

Relay Therapeutics announced it will present initial clinical and preclinical data on its lead drug candidate, zovegalisib, a mutant-selective PI3Kα inhibitor, in PIK3CA-driven vascular anomalies at the ISSVA World Congress 2026. Zovegalisib is also in advanced development for HR+/HER2- metastatic breast cancer and aims to address a large patient p…

Oportun Provides Updates on Leadership Transition

Oportun Provides Updates on Leadership Transition

Oportun Financial Corporation announced that Kate Layton and Gaurav Rana will serve as interim co-CEOs following the departure of CEO Raul Vazquez. Both executives will retain their current roles while leading the company during the CEO search. Vazquez will continue as an advisor until July 2026 to facilitate a smooth transition. The board is activ…

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

Safe Bulkers, Inc., a marine drybulk transportation services provider, announced quarterly cash dividends of $0.50 per share on its 8.00% Series C and Series D Cumulative Redeemable Perpetual Preferred Shares, payable on April 30, 2026. Future dividends remain at the discretion of the Board of Directors, depending on company performance and financi…

Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs

Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs

Adagene Inc., a clinical-stage biotech company specializing in novel antibody-based cancer immunotherapies, announced the pricing of an underwritten public offering of 18.67 million ADSs at $3.75 each, raising gross proceeds of approximately $70 million. The offering attracted participation from both new and existing institutional investors and is …